retatrutide triple agonist glp-1 gip glucagon ly3437943 🧬Retatrutide (LY3437943) — The Triple-Agonist Powerhouse activates GLP-1, GIP, and receptors simultaneously, setting it apart from single or dual-action drugs like semaglutide and tirzepatide. 📊 Clinical Data — All Phases Glucagon and retatrutide‐induced ANGPTL3/8 secretion
Pay in 4 interest-free payments of $6.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

























